|
Showing the most relevant articles for your search:AMEX:ANX | Date | Time | Source | Headline | Symbol | Company | | 03/17/2008 | 6:00AM | Edgar (US Regulatory) | Adventrx Pharmaceuticals Inc - Annual Report (10-K) | AMEX:ANX | Mast Therapeutics, Inc. |
| 03/13/2008 | 4:10PM | Edgar (US Regulatory) | Adventrx Pharmaceuticals Inc - Current report filing (8-K) | AMEX:ANX | Mast Therapeutics, Inc. |
| 03/13/2008 | 4:01PM | PR Newswire (US) | ADVENTRX Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2007 Financial Results | AMEX:ANX | Mast Therapeutics, Inc. |
| 03/12/2008 | 6:00AM | PR Newswire (US) | ADVENTRX to Present CoFactor Phase 2 Breast Cancer Data at the 2008 Annual Meeting of the American Society of Clinical Oncology | AMEX:ANX | Mast Therapeutics, Inc. |
| 03/10/2008 | 7:00AM | PR Newswire (US) | Complete ANX-530 Safety Data to be Published in the 2008 Proceedings of the American Society of Clinical Oncology | AMEX:ANX | Mast Therapeutics, Inc. |
| 03/06/2008 | 6:00AM | PR Newswire (US) | ADVENTRX Pharmaceuticals to Report Fourth Quarter and Year End 2007 Results | AMEX:ANX | Mast Therapeutics, Inc. |
| 03/03/2008 | 1:46PM | Edgar (US Regulatory) | Adventrx Pharmaceuticals Inc - Initial Statement of Beneficial Ownership (3) | AMEX:ANX | Mast Therapeutics, Inc. |
| 02/25/2008 | 11:47AM | Edgar (US Regulatory) | Adventrx Pharmaceuticals Inc - Current report filing (8-K) | AMEX:ANX | Mast Therapeutics, Inc. |
| 02/25/2008 | 6:00AM | PR Newswire (US) | Eric K. Rowinsky Joins ADVENTRX Board of Directors | AMEX:ANX | Mast Therapeutics, Inc. |
| 02/07/2008 | 6:00AM | PR Newswire (US) | ADVENTRX to Present Complete ANX-530 Pharmacokinetic Data at the 2008 American Association for Cancer Research Annual Meeting | AMEX:ANX | Mast Therapeutics, Inc. |
| 02/05/2008 | 6:00AM | PR Newswire (US) | ADVENTRX Pharmaceuticals to Present at The 10th Annual BIO CEO & Investor Conference | AMEX:ANX | Mast Therapeutics, Inc. |
| 01/31/2008 | 6:00AM | PR Newswire (US) | ADVENTRX to Present ANX-201 Preclinical Data at Keystone Symposia HIV Pathogenesis Conference | AMEX:ANX | Mast Therapeutics, Inc. |
| 01/30/2008 | 6:03AM | Edgar (US Regulatory) | Adventrx Pharmaceuticals Inc - Current report filing (8-K) | AMEX:ANX | Mast Therapeutics, Inc. |
| 01/30/2008 | 6:00AM | PR Newswire (US) | ADVENTRX Announces Consolidation of Clinical and Management Positions | AMEX:ANX | Mast Therapeutics, Inc. |
| 01/14/2008 | 6:31AM | Edgar (US Regulatory) | Adventrx Pharmaceuticals Inc - Current report filing (8-K) | AMEX:ANX | Mast Therapeutics, Inc. |
| 01/14/2008 | 6:30AM | PR Newswire (US) | ADVENTRX Announces ANX-530 Safety Data and Provides NDA Submission Guidance | AMEX:ANX | Mast Therapeutics, Inc. |
| 01/14/2008 | 6:04AM | Edgar (US Regulatory) | Adventrx Pharmaceuticals Inc - Current report filing (8-K) | AMEX:ANX | Mast Therapeutics, Inc. |
| 12/19/2007 | 2:40PM | Edgar (US Regulatory) | Adventrx Pharmaceuticals Inc - Amended Statement of Beneficial Ownership (SC 13D/A) | AMEX:ANX | Mast Therapeutics, Inc. |
| 12/19/2007 | 1:20PM | Edgar (US Regulatory) | Adventrx Pharmaceuticals Inc - Current report filing (8-K) | AMEX:ANX | Mast Therapeutics, Inc. |
| 12/17/2007 | 12:17PM | Edgar (US Regulatory) | Adventrx Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4) | AMEX:ANX | Mast Therapeutics, Inc. |
| 12/17/2007 | 11:43AM | Edgar (US Regulatory) | Adventrx Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4) | AMEX:ANX | Mast Therapeutics, Inc. |
| 12/10/2007 | 6:00AM | PR Newswire (US) | ADVENTRX Pharmaceuticals to Present at the 2007 RBC Capital Markets Healthcare Conference | AMEX:ANX | Mast Therapeutics, Inc. |
| 12/05/2007 | 6:00AM | PR Newswire (US) | ADVENTRX Announces Completion of Patient Enrollment in Phase 2 Clinical Trial of CoFactor(R) for the Treatment of Advanced Breas | AMEX:ANX | Mast Therapeutics, Inc. |
| 11/16/2007 | 6:06AM | Edgar (US Regulatory) | Adventrx Pharmaceuticals Inc - Current report filing (8-K) | AMEX:ANX | Mast Therapeutics, Inc. |
| 11/16/2007 | 6:00AM | PR Newswire (US) | ADVENTRX Meets Primary Endpoint in ANX-530 Marketing-Enabling Clinical Study | AMEX:ANX | Mast Therapeutics, Inc. |
| 11/07/2007 | 5:02PM | Edgar (US Regulatory) | Adventrx Pharmaceuticals Inc - Quarterly Report (10-Q) | AMEX:ANX | Mast Therapeutics, Inc. |
| 11/07/2007 | 4:07PM | Edgar (US Regulatory) | Adventrx Pharmaceuticals Inc - Current report filing (8-K) | AMEX:ANX | Mast Therapeutics, Inc. |
| 11/07/2007 | 4:01PM | PR Newswire (US) | ADVENTRX Pharmaceuticals Reports Third Quarter 2007 Financial Results | AMEX:ANX | Mast Therapeutics, Inc. |
| 11/05/2007 | 6:00AM | PR Newswire (US) | ADVENTRX Pharmaceuticals to Present at the 13th Annual BIO-Europe Partnering Conference | AMEX:ANX | Mast Therapeutics, Inc. |
| 11/02/2007 | 8:00AM | PR Newswire (US) | ADVENTRX Provides Update on Cofactor(R) Program | AMEX:ANX | Mast Therapeutics, Inc. |
|
Showing the most relevant articles for your search:AMEX:ANX |
|